ATE256148T1 - Menschliche monoklonale antikörper gegen das hepatitis b oberflächenantigen - Google Patents

Menschliche monoklonale antikörper gegen das hepatitis b oberflächenantigen

Info

Publication number
ATE256148T1
ATE256148T1 AT97924227T AT97924227T ATE256148T1 AT E256148 T1 ATE256148 T1 AT E256148T1 AT 97924227 T AT97924227 T AT 97924227T AT 97924227 T AT97924227 T AT 97924227T AT E256148 T1 ATE256148 T1 AT E256148T1
Authority
AT
Austria
Prior art keywords
hbvsag
antibodies
cell lines
surface antigen
mice
Prior art date
Application number
AT97924227T
Other languages
English (en)
Inventor
Yair Reisner
Shlomo Dagan
Original Assignee
Yeda Res & Dev
Xtl Biopharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev, Xtl Biopharmaceuticals Ltd filed Critical Yeda Res & Dev
Application granted granted Critical
Publication of ATE256148T1 publication Critical patent/ATE256148T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/46—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—DNA viruses
    • C07K16/082—Hepadnaviridae (F), e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Environmental Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT97924227T 1996-06-11 1997-06-10 Menschliche monoklonale antikörper gegen das hepatitis b oberflächenantigen ATE256148T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL11862596A IL118625A0 (en) 1996-06-11 1996-06-11 Anti HBV antibodies
PCT/IL1997/000184 WO1997047654A1 (en) 1996-06-11 1997-06-10 Human monoclonal antibodies to the hepatitis b surface antigen

Publications (1)

Publication Number Publication Date
ATE256148T1 true ATE256148T1 (de) 2003-12-15

Family

ID=11068955

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97924227T ATE256148T1 (de) 1996-06-11 1997-06-10 Menschliche monoklonale antikörper gegen das hepatitis b oberflächenantigen

Country Status (11)

Country Link
US (2) USRE40831E1 (de)
EP (1) EP0912611B9 (de)
JP (1) JP3672933B2 (de)
AT (1) ATE256148T1 (de)
AU (1) AU2975697A (de)
DE (1) DE69726734T2 (de)
DK (1) DK0912611T3 (de)
ES (1) ES2210527T3 (de)
IL (1) IL118625A0 (de)
PT (1) PT912611E (de)
WO (1) WO1997047654A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL118626A0 (en) 1996-06-11 1996-10-16 Xtl Biopharmaceuticals Limited Anti HBV antibody
DE19726597C1 (de) * 1997-06-23 1998-11-19 Wengler Georg S Verfahren zur Herstellung von monoklonalen Antikörper
JP2004517636A (ja) * 2000-10-02 2004-06-17 コリア リサーチ インスティテュート オブ バイオサイエンス アンド バイオテクノロジー Ｂ型肝炎ウイルスの表面抗原ｓに対するヒト化抗体及びその製造方法
SG153666A1 (en) * 2001-10-04 2009-07-29 Yeda Res & Dev Treatment of hepatitis b virus infection with human monoclonal antibodies
EP1432418A1 (de) * 2001-10-04 2004-06-30 XTL Biopharmaceuticals Limited Behandlung einer hepatitis b infektion mit humanen monoklonalen antikörpern
KR100467706B1 (ko) * 2002-01-15 2005-01-24 주식회사 녹십자홀딩스 Ｂ형 간염 바이러스의 표면 항원에 대한 인간항체
WO2003068915A2 (en) * 2002-02-11 2003-08-21 Alexion Pharmaceuticals, Inc. Production of human antibodies in immunodeficient, non-human, mammalian hosts
AU2003210060B2 (en) 2002-03-22 2010-02-25 Aprogen, Inc. Humanized antibody and process for preparing same
DE60336063D1 (de) * 2002-05-31 2011-03-31 Childrens Hosp Medical Center Verfahren, zusammensetzung und kit für die antigenbindung von norwalk-ähnlichen viren
US7977098B2 (en) 2002-05-31 2011-07-12 Children's Hospital Medical Center Antigenic binding patterns of norovirus to human histo-blood group antigens
CA2594922A1 (en) * 2005-01-14 2006-07-20 The Government Of The United States Of America, As Represented By The Se Cretary, Department Of Health And Human Services Monoclonal antibodies that bind or neutralize hepatitis b virus
CA2604840A1 (en) 2005-04-18 2006-10-26 Xtl Biopharmaceuticals Ltd. Stabilized anti-hepatitis b (hbv) antibody formulations
US20110152263A1 (en) * 2006-11-16 2011-06-23 Xi Jiang Composition and method for inhibiting norovirus infection
US20100150942A1 (en) * 2008-12-03 2010-06-17 Cantor Thomas L Affinity purified human polyclonal antibodies and methods of making and using them
EP2440582B1 (de) 2009-06-09 2018-11-07 Children's Hospital Medical Center Monomere und dimere der antigen-norovirus-p-domäne, moleküle aus antigen-norovirus-partikeln sowie verfahren zu ihrer herstellung und verwendung
TWI620568B (zh) * 2012-08-30 2018-04-11 雷普利可公司 用於治療ｂ型肝炎及ｄ型肝炎感染之方法
KR20150070181A (ko) 2012-09-27 2015-06-24 크루셀 홀란드 비.브이. B형 간염 바이러스에 결합하고 이를 중화시킬 수 있는 인간 결합 분자 및 그의 용도
AR093447A1 (es) * 2012-11-13 2015-06-10 Genentech Inc Enriquecimiento de plasmablastos especificos de antigeno
US9321803B2 (en) 2013-07-12 2016-04-26 Children's Hospital Medical Center Compositions and methods for inhibiting norovirus infection
EP3519436A4 (de) * 2016-09-30 2020-09-09 Baylor College of Medicine Antikörperbasierte gentherapie mit gewebegerichteter expression
US11833198B2 (en) 2017-03-28 2023-12-05 Children's Hospital Medical Center Norovirus S particle based vaccines and methods of making and using same
WO2025240246A1 (en) 2024-05-13 2025-11-20 Gilead Sciences, Inc. Combination therapies with ribavirin

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61104796A (ja) * 1984-10-26 1986-05-23 Chemo Sero Therapeut Res Inst モノクロ−ナル抗体の製造方法
EP0438053B1 (de) * 1990-01-15 1999-06-16 Yeda Research And Development Company Limited Dauerhafte Verpflanzung und Entwicklung menschlicher hämatopoietischer Zellinien bei normalen Säugetieren
US5652373A (en) 1990-01-15 1997-07-29 Yeda Research And Development Co. Ltd. Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems
US5849288A (en) 1990-01-15 1998-12-15 Yeda Research And Development Co. Ltd. Method for production of monoclonal antibodies in chimeric mice or rats having xenogeneic antibody-producing cells
US5849987A (en) 1992-06-02 1998-12-15 Yeda Research And Development Co. Ltd. Animal model for hepatitis virus infection
US5858328A (en) 1991-06-04 1999-01-12 Yeda Research And Development Co. Ltd. Animal model for hepatitis virus infection
US5804160A (en) 1991-06-04 1998-09-08 Yeda Research And Development Co. Ltd Animal model for hepatitis virus infection
US5866757A (en) 1992-06-02 1999-02-02 Yeda Research And Development Co. Ltd. Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems
CA2147600A1 (en) * 1992-11-06 1994-05-26 Lars G. Ostberg Production of human monoclonal antibodies active against hepatitis b surface antigen
EP0698042A1 (de) * 1993-05-10 1996-02-28 Stichting Centraal Laboratorium van de Bloedtransfusiedienst van het Nederlandse Rode Kruis Antikoerperzusammensetzung gegen hepatitis-b-virus oberflaechenantigen

Also Published As

Publication number Publication date
US6254867B1 (en) 2001-07-03
ES2210527T3 (es) 2004-07-01
WO1997047654A1 (en) 1997-12-18
AU2975697A (en) 1998-01-07
JP3672933B2 (ja) 2005-07-20
DK0912611T3 (da) 2004-03-29
DE69726734D1 (de) 2004-01-22
EP0912611A1 (de) 1999-05-06
EP0912611B1 (de) 2003-12-10
EP0912611B9 (de) 2004-12-01
DE69726734T2 (de) 2004-09-30
IL118625A0 (en) 1996-10-16
JP2000513215A (ja) 2000-10-10
PT912611E (pt) 2004-04-30
USRE40831E1 (en) 2009-07-07

Similar Documents

Publication Publication Date Title
ATE256148T1 (de) Menschliche monoklonale antikörper gegen das hepatitis b oberflächenantigen
IL118626A0 (en) Anti HBV antibody
Heston et al. New Epstein–Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma
Herlyn et al. Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody
EREN et al. Human monoclonal antibodies specific to hepatitis B virus generated in a human/mouse radiation chimera: the Trimera system
ATE14454T1 (de) Monoklonaler antikoerper gegen menschliche helfer- t-zellen, verfahren zu seiner herstellung, ihn produzierende hybridzellinie, seine diagnostischen und therapeutischen verwendungen und diesen antikoerper enthaltende diagnostische und therapeutische zusammensetzungen.
ATE13317T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches prothymozytantigen; antikoerper und verfahren zu seiner herstellung; diagnostische und therapeutische verwendungen und diesen antikoerper enthaltende pharmazeutische zusammensetzungen.
EP0517815A4 (en) An igg-1 human monoclonal antibody reactive with an hiv-1 glycoprotein and method of use
ATE13692T1 (de) Hybridzellinie zur herstellung komplementfixierender monoklonaler antikoerper gegen menschliche suppressor-t-zellen; antikoerper und verfahren zu seiner herstellung; diagnostische und therapeutische verwendungen und diesen antikoerper enthaltende pharmazeutische zusammensetzungen.
ATE14233T1 (de) Monoklonaler antikoerper gegen menschliche tzellen, verfahren zu seiner herstellung, ihn produzierende hybridzellinie, ihn enthaltende therapeutische zusammensetzung und ihn verwendendes diagnostisches verfahren.
ATE14899T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches monozytantigen, antikoerper und verfahren.
ATE13693T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches fruehes thymozyt-antigen; antikoerper und verfahren zu seiner herstellung; diagnostische und therapeutische verwendungen und diesen antikoerper enthaltende pharmazeutische zusammensetzungen.
YU306680A (en) Method of obtaining monoclonal antibodies
DE60141832D1 (de) Humaner monoklonaler antikörper gegen das hepatitis c virus e2 glykoprotein
CA2254931A1 (en) Human monoclonal antibodies to the hepatitis b surface antigen
Desgranges et al. High affinity human monoclonal antibodies directed against hepatitis B surface antigen
RU95117092A (ru) Антитела, смесь антител, fab-фрагмент, линии гибридомных клеток, способы создания линий клеток, способ борьбы с вирусом, способ снижения уровня антигена, днк
JPH08509974A (ja) Ｂ型肝炎表面抗原に対する抗体の組成物
RU93019968A (ru) Штамм гибридных культивируемых клеток животного mus musculus - продуцент моноклональных антител к с-концевой части белка р24 вируса иммунодефицита человека i типа
Sa'adu et al. Epitope mapping of HBsAg using a panel of human anti-HBs antibodies
Takebe et al. The Analyses of Human-Human Hybridomas Producing Human Type Antibody for a Long Term Derived from Pregnant Women's Peripheral Blood Lymphocyte

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0912611

Country of ref document: EP

EEIH Change in the person of patent owner